» Articles » PMID: 39062788

The Role of Glia in Wilson's Disease: Clinical, Neuroimaging, Neuropathological and Molecular Perspectives

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jul 27
PMID 39062788
Authors
Affiliations
Soon will be listed here.
Abstract

Wilson's disease (WD) is inherited in an autosomal recessive manner and is caused by pathogenic variants of the gene, which are responsible for impaired copper transport in the cell, inhibition of copper binding to apoceruloplasmin, and biliary excretion. This leads to the accumulation of copper in the tissues. Copper accumulation in the CNS leads to the neurological and psychiatric symptoms of WD. Abnormalities of copper metabolism in WD are associated with impaired iron metabolism. Both of these elements are redox active and may contribute to neuropathology. It has long been assumed that among parenchymal cells, astrocytes have the greatest impact on copper and iron homeostasis in the brain. Capillary endothelial cells are separated from the neuropil by astrocyte terminal legs, putting astrocytes in an ideal position to regulate the transport of iron and copper to other brain cells and protect them if metals breach the blood-brain barrier. Astrocytes are responsible for, among other things, maintaining extracellular ion homeostasis, modulating synaptic transmission and plasticity, obtaining metabolites, and protecting the brain against oxidative stress and toxins. However, excess copper and/or iron causes an increase in the number of astrocytes and their morphological changes observed in neuropathological studies, as well as a loss of the copper/iron storage function leading to macromolecule peroxidation and neuronal loss through apoptosis, autophagy, or cuproptosis/ferroptosis. The molecular mechanisms explaining the possible role of glia in copper- and iron-induced neurodegeneration in WD are largely understood from studies of neuropathology in Parkinson's disease and Alzheimer's disease. Understanding the mechanisms of glial involvement in neuroprotection/neurotoxicity is important for explaining the pathomechanisms of neuronal death in WD and, in the future, perhaps for developing more effective diagnostic/treatment methods.

Citing Articles

Psychiatric Symptoms in Wilson's Disease-Consequence of Gene Mutations or Just Coincidence?-Possible Causal Cascades and Molecular Pathways.

Gromadzka G, Antos A, Sorysz Z, Litwin T Int J Mol Sci. 2024; 25(22).

PMID: 39596417 PMC: 11595239. DOI: 10.3390/ijms252212354.

References
1.
Friedrich I, Reimann K, Jankuhn S, Kirilina E, Stieler J, Sonntag M . Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease. Acta Neuropathol Commun. 2021; 9(1):47. PMC: 7986300. DOI: 10.1186/s40478-021-01145-2. View

2.
McNeill A, Birchall D, Hayflick S, Gregory A, Schenk J, Zimmerman E . T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology. 2008; 70(18):1614-9. PMC: 2706154. DOI: 10.1212/01.wnl.0000310985.40011.d6. View

3.
Scheiber I, Mercer J, Dringen R . Metabolism and functions of copper in brain. Prog Neurobiol. 2014; 116:33-57. DOI: 10.1016/j.pneurobio.2014.01.002. View

4.
Antos A, Czlonkowska A, Bembenek J, Skowronska M, Kurkowska-Jastrzebska I, Litwin T . Blood Based Biomarkers of Central Nervous System Involvement in Wilson's Disease. Diagnostics (Basel). 2023; 13(9). PMC: 10177361. DOI: 10.3390/diagnostics13091554. View

5.
Zheng Z, White C, Lee J, Peterson T, Bush A, Sun G . Altered microglial copper homeostasis in a mouse model of Alzheimer's disease. J Neurochem. 2010; 114(6):1630-8. PMC: 2945454. DOI: 10.1111/j.1471-4159.2010.06888.x. View